First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 34(34): 4142-4150, 2016 12.
Article
in En
| MEDLINE
| ID: mdl-26926685
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triazoles
/
Hydrazines
/
Neoplasms
Type of study:
Guideline
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2016
Document type:
Article